Abstract
Over the last decade, personalized medicine has become a buzz word, which covers a broad spectrum of meanings and generates many different opinions. The purpose of this article is to achieve a better understanding of the reasons why personalized medicine gives rise to such conflicting opinions. We show that a major issue of personalized medicine is the gap existing between its claims and its reality. We then present and analyze different possible reasons for this gap. We propose an hypothesis inspired by the Windelband’s distinction between nomothetic and idiographic methodology. We argue that the fuzzy situation of personalized medicine results from a mix between idiographic claims and nomothetic methodological procedures. Hence we suggest that the current quandary about personalized medicine cannot be solved without getting involved in a discussion about the complex epistemological and methodological status of medicine. To conclude, we show that the Gadamer’s view of medicine as a dialogical process can be fruitfully used and reveals that personalization is not a theoretical task, but a practical one, which takes place within the clinical encounter.
Similar content being viewed by others
References
Árnason, Vilhjálmur. 2012. The personal is political: Ethics and personalized medicine. Ethical Perspectives 19(1): 103–122.
Bensaude-Vincent, Bernadette. 2014. The politics of buzzwords at the interface of technoscience, market and society: The case of ‘public engagement in science’. Public Understanding of Science 23(3): 238–253.
Buzzoni, Marco. 2003. Medicine as a human science between the singularity of the patient and technical scientific reproducibility. Poiesis & Praxis 1(3): 171–184.
Chadwick, Ruth. 2014. The ethics of personalized medicine: A philosopher’s perspective. Personalized Medicine 11(1): 5–6.
Dion-Labrie, Marianne, Marie-Chantal Fortin, Marie-Josée Hébert, and Hubert Doucet. 2008. Réflexions éthiques sur la médecine personnalisée: l’alliance de la science et de la médecine enfin réalisée? Revista Colombiana de Bioética 3(2): 33–56.
Fleck, Leonard M. 2010. Personalized medicine’s ragged edge. The Hastings Center Report 40(5): 16–18.
Gadamer, Hans-Georg. 1996. The enigma of health: the art of healing in a scientific age. Stanford: Stanford University Press.
Gadamer, Hans-Georg. 2004. Truth and method. London, New York: Continuum.
Green, Eric D., Mark S. Guyer, and The National Human Genome Research Institute. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333): 204–213.
Hedgecoe, Adam. 2004. The politics of personalised medicine: Pharmacogenetics in the clinic. Cambridge: Cambridge University Press.
Heßling, Arndt, and Silke Schicktanz. 2012. What German experts expect from individualized medicine: Problems of uncertainty and future complication in physician–patient interaction. Clinical Ethics 7(2): 86–93.
Jain, Kewal. 2015. Textbook of personalized medicine, 2nd ed. New York: Springer.
Johnson, Julie A. 2008. Ethnic differences in cardiovascular drug response potential contribution of pharmacogenetics. Circulation 118(13): 1383–1393.
Kalow, Werner. 2001. Interethnic differences in drug response. Drugs and the Pharmaceutical Sciences 113: 109–134.
Kuhn, Thomas Samuel. 1970. The structure of scientific revolutions. Chicago and London: The University of Chicago Press.
Langanke, Martin, Wolfgang Lieb, Pia Erdmann, Marcus Dörr, Tobias Fischer, Heyo K. Kroemer, Steffen Flessa and Heinrich Assel. 2015. The Meaning of “Individualized Medicine”: A Terminological Adjustment of a Perplexing Term. In Individualized Medicine. Ethical, economical and historical perspectives, ed. Tobias Fischer, Martin Langanke, Paul Marschall and Susanne Michl, 11–28. Heidelberg, New York Dordrecht London: Springer.
Michl, Susanne. 2015. Inventing traditions, raising expectations. Recent debates on “Personalized Medicine”. In Individualized medicine. Ethical, economical and historical perspectives, ed. Tobias Fischer, Martin Langanke, Paul Marschall, and Susanne Michl, 45–60. New York: Springer.
Nelkin, Dorothy. 1994. Promotional metaphors and their popular appeal. Public Understanding of Science 3(1): 25–31.
Offit, Kenneth. 2011. Personalized medicine: New genomics, old lessons. Human Genetics 130(1): 3–14.
Papavassiliou, Athanasios G. 2010. Molecular medicine: Prometheus unbound. BioEssays 32(6): 453. doi:10.1002/bies.201090017.
Pokorska-Bocci, Anna, Alison Stewart, Gurdeep S. Sagoo, Alison Hall, Mark Kroese, and Hilary Burton. 2014. “Personalized medicine”: What’s in a name? Personalized Medicine 11(2): 197–210.
Schleidgen, Sebastian, Corinna Klingler, Teresa Bertram, Wolf H. Rogowski, and Georg Marckmann. 2013. What is personalized medicine: Sharpening a vague term based on a systematic literature review. BMC Medical Ethics 14(1): 55.
Schleidgen, Sebastian, and Georg Marckmann. 2013. Alter Wein in neuen Schläuchen? Ethische Implikationen der Individualisierten Medizin. Ethik in der Medizin 25(3): 223–231.
Smart, Andrew, Paul Martin, and Michael Parker. 2004. Tailored medicine: Whom will it fit? The ethics of patient and disease stratification. Bioethics 18: 322–343.
Steele, Fintan R. 2009. Personalized medicine: something old, something new. Personalized Medicine 6: 1–5.
Svenaeus, Fredrik. 2000a. Hermeneutics of clinical practice: The question of textuality. Theoretical Medicine and Bioethics 21(2): 171–189.
Svenaeus, Fredrik. 2000b. The hermeneutics of medicine and the phenomenology of health: Steps towards a philosophy of medical practice. Dordrecht, Boston, London: Kluwer Academic Publishers.
Svenaeus, Fredrik. 2003. Hermeneutics of medicine in the wake of Gadamer: The issue of phronesis. Theoretical Medicine and Bioethics 24(5): 407–431.
Sykiotis, Gerasimos P., George D. Kalliolias, and Athanasios G. Papavassiliou. 2005. Pharmacogenetic principles in the Hippocratic writings. The Journal of Clinical Pharmacology 45(11): 1218–1220.
Tutton, Richard. 2012. Personalizing medicine: Futures present and past. Social Science and Medicine 75(10): 1721–1728.
van Lente, Harro, and Arie Rip. 1998. The rise of membrane technology from Rhetorics to social reality. Social Studies of Science 28(2): 221–254.
Vollmann, Jochen. 2013. Persönlicher-besser-kostengünstiger? Kritische medizinethische Anfragen an die „personalisierte Medizin. Ethik in der Medizin 3(25): 233–241.
What Happened to Personalized Medicine?. 2012. Nature Biotechnology 30 (1): 1–1.
Windelband, Wilhelm. 1980. History and natural science. History and Theory 19(2): 169–185.
Yurkiewicz, Shara. 2010. The prospects for personalized medicine. The Hastings Center Report 40(5): 14–16.
Acknowledgments
The author would like to thank Pascaline Rocher for her help in editing the initial manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abettan, C. Between hype and hope: What is really at stake with personalized medicine?. Med Health Care and Philos 19, 423–430 (2016). https://doi.org/10.1007/s11019-016-9697-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-016-9697-2